Hung Tseng to Cohort Studies
This is a "connection" page, showing publications Hung Tseng has written about Cohort Studies.
Connection Strength
2.334
-
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States. Nat Commun. 2023 09 20; 14(1):5851.
Score: 0.145
-
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study. Vaccine. 2023 06 29; 41(29):4212-4219.
Score: 0.142
-
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study. Vaccine. 2023 06 01; 41(24):3636-3646.
Score: 0.141
-
Risk of herpes zoster following mRNA COVID-19 vaccine administration. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):643-649.
Score: 0.138
-
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy. Vaccine. 2022 Jul 30; 40(32):4503-4512.
Score: 0.133
-
Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study. PLoS One. 2022; 17(4):e0267824.
Score: 0.132
-
Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection. J Infect Dis. 2020 09 14; 222(8):1298-1310.
Score: 0.118
-
Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization. BMC Health Serv Res. 2017 07 21; 17(1):503.
Score: 0.094
-
Receipt of thyroid hormone deficiency treatment and risk of herpes zoster. Int J Infect Dis. 2017 Jun; 59:90-95.
Score: 0.093
-
Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds. Pediatrics. 2017 01; 139(1).
Score: 0.091
-
Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease. Clin Infect Dis. 2016 Feb 15; 62(4):462-7.
Score: 0.085
-
Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. J Infect Dis. 2015 Oct 15; 212(8):1222-31.
Score: 0.081
-
Vaccination against zoster remains effective in older adults who later undergo chemotherapy. Clin Infect Dis. 2014 Oct; 59(7):913-9.
Score: 0.077
-
Trends and disparity in zoster vaccine uptake in a managed care population. Vaccine. 2013 Sep 23; 31(41):4564-8.
Score: 0.072
-
Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis. 2013 Feb; 56(3):315-21.
Score: 0.068
-
Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study. Vaccine. 2012 Aug 17; 30(38):5625-30.
Score: 0.067
-
Correlates for second-dose varicella vaccination in school-age children in a managed care organization in California. Pediatr Infect Dis J. 2012 Jul; 31(7):752-5.
Score: 0.067
-
Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population. J Infect Dis. 2012 Jul 15; 206(2):190-6.
Score: 0.066
-
Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. J Intern Med. 2012 May; 271(5):510-20.
Score: 0.064
-
Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011 Jan 12; 305(2):160-6.
Score: 0.060
-
Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA. 2010 May 05; 303(17):1699-706.
Score: 0.057
-
Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study. Pediatr Infect Dis J. 2010 Mar; 29(3):205-8.
Score: 0.057
-
Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002-2008. Pediatr Infect Dis J. 2009 Dec; 28(12):1069-72.
Score: 0.056
-
Population-based epidemiological study of neurological diseases in Taiwan: I. Creutzfeldt-Jakob disease and multiple sclerosis. Neuroepidemiology. 2009; 33(3):247-53.
Score: 0.054
-
Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States. Vaccine. 2023 07 12; 41(31):4571-4578.
Score: 0.036
-
Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System. JAMA Netw Open. 2023 Jan 03; 6(1):e2251833.
Score: 0.034
-
A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination. Vaccine. 2023 01 16; 41(3):844-854.
Score: 0.034
-
Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011. Vaccine. 2016 Jan 02; 34(1):167-71.
Score: 0.021
-
Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizures. Vaccine. 2014 Nov 12; 32(48):6408-14.
Score: 0.019
-
Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort. Vaccine. 2014 May 07; 32(22):2574-81.
Score: 0.019
-
Red wine consumption not associated with reduced risk of colorectal cancer. Nutr Cancer. 2010; 62(6):849-55.
Score: 0.014